Florida Governor Ron DeSantis shredded President Joe Biden’s administration over the decision to revoke the emergency use authorization for Regeneron and Eli Lilly monoclonal antibody treatments.
According to the Food and Drug Administration, the treatments are not effective against the Omicron variant. Because the variant accounts for most cases of the coronavirus across the country, leaders of the agency limited its use.
Read the full story
Following a catastrophic U.S. military withdrawal from Afghanistan, the highest inflation since 2008,pushing unpopular COVID vaccine mandates, rationing COVID treatments to red states and finally, watching his domestic legislative agenda falter in Congress, President Joe Biden is already upside down on his job approval ratings, according to the latest average of polls compiled by RealClearPolitics.com.
Reuters/Ipsos on Sept. 29-30 had Biden’s approval at 46 percent and disapproval at 50 percent.
Read the full story
Florida Governor Ron DeSantis announced on Thursday that the state of Florida purchased thousands of monoclonal antibody treatments directly from GlaxoSmithKline, a producer of the treatment.
The move by DeSantis bypasses a restriction placed by President Joe Biden’s administration, allowing the federal government to dictate allocations to each state and leave it to state leaders to ration it out among locations.
Read the full story
Wednesday morning on the Tennessee Star Report, host Michael Patrick Leahy welcomed Maury County Tennessee State Representative Scott Cepicky to the newsmakers line to discuss monoclonal antibody guidelines, calling a special session, and circumventing the federal government.
Read the full story
Officials with two pharmaceutical companies who produce monoclonal antibody treatments said Wednesday that the U.S. government distributes the currently-available supply of those treatments and that those companies may not sell them to hospitals or state governments. A spokesman for the New York state-based Regeneron, who identified himself only as Alex, said the U.S. government owns the currently available supply of REGEN-COV, which is the company’s monoclonal antibody treatment. The U.S. government allocates that product to state governments.
Read the full story